We were interested to read the paper by Eng and colleagues on paternal lineage early onset hereditary ovarian cancers [1] . They found by exome sequencing of 159 non-BRCA1/2 ovarian cancer cases that one missense variant (rs176026 in MAGEC3) was associated with risk at "chromosome-wide significance" (Hazard ratio [HR] = 2.85, 95% CI 1.75-4.65) and with a 6.7-year-earlier age of onset. They also report some in silico analyses of rs176026 and MAGEC3. However, other publicly available data on ovarian cancer risk for this SNP do not support these findings. In an analysis by the Ovarian Cancer Association Consortium (OCAC) [2] , in over 25,000 ovarian cancer cases and 40,000 controls, no significant association was found for overall ovarian cancer risk (P = 0.24) or for any histological subtypes examined (P = 0.20 for high-grade serous ovarian cancer). In this data set, rs176026 was imputed with an imputation r-squared of 0.79.
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